{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:20:33Z","timestamp":1794007233675,"version":"4.8.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Robert Koch Institute"},{"name":"Ciberned","award":["BESAD-P"],"award-info":[{"award-number":["BESAD-P"]}]},{"name":"Spanish Ministry of Health - Instituto Carlos III\/Fondo Social Europeo","award":["CP16\/00041"],"award-info":[{"award-number":["CP16\/00041"]}]},{"name":"MINECO","award":["AGL2015-71764-REDT"],"award-info":[{"award-number":["AGL2015-71764-REDT"]}]},{"name":"DAAD - IKYDA","award":["57260006"],"award-info":[{"award-number":["57260006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13024-017-0226-4","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T12:20:43Z","timestamp":1510316443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":220,"title":["YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias"],"prefix":"10.1186","volume":"12","author":[{"given":"Franc","family":"Llorens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Th\u00fcne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqas","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Kanata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Diaz-Lucena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Xanthopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Kovatsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Pleschka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Garcia-Esparcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duru","family":"Ozbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c2ngela","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Milosevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Andr\u00e9oletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Fern\u00e1ndez-Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina M.","family":"Vorberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Glatzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Sklaviadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Maria","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Krasemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"S\u00e1nchez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,10]]},"reference":[{"key":"226_CR1","first-page":"5","volume":"51","author":"MH Kazakova","year":"2009","unstructured":"Kazakova MH, Sarafian VS. YKL-40--a novel biomarker in clinical practice? Folia Med. 2009;51:5\u201314.","journal-title":"Folia Med"},{"key":"226_CR2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1432-1327.1998.2510504.x","volume":"251","author":"GH Renkema","year":"1998","unstructured":"Renkema GH, Boot RG, Au FL, Donker-Koopman WE, Strijland A, Muijsers AO, et al. Chitotriosidase a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem. 1998;251:504\u20139.","journal-title":"Eur J Biochem"},{"key":"226_CR3","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3390\/cancers2031453","volume":"2","author":"NA Schultz","year":"2010","unstructured":"Schultz NA, Johansen JS. YKL-40-a protein in the field of translational medicine: A role as a biomarker in cancer patients? Cancers (Basel). 2010;2:1453\u201391.","journal-title":"Cancers (Basel)"},{"key":"226_CR4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fphys.2013.00122","volume":"4","author":"R Shao","year":"2013","unstructured":"Shao R. YKL-40 acts as an angiogenic factor to promote tumor angiogenesis. Front. Physiol. 2013;4:122.","journal-title":"Front. Physiol"},{"key":"226_CR5","doi-asserted-by":"crossref","unstructured":"Ringsholt M, H\u00f8gdall EVS, Johansen JS, Price PA, Christensen LH. YKL-40 protein expression in normal adult human tissues \u2013 an immunohistochemical study. J Mol Histol [Internet] 2007;38:33\u201343. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17242979 , http:\/\/link.springer.com\/10.1007\/s10735-006-9075-0","DOI":"10.1007\/s10735-006-9075-0"},{"key":"226_CR6","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1038\/onc.2009.292","volume":"28","author":"R Shao","year":"2009","unstructured":"Shao R, Hamel K, Petersen L, Cao QJ, Arenas RB, Bigelow C, et al. YKL-40, a secreted glycoprotein, promotes tumor angiogenesis. Oncogene. 2009;28:4456\u201368. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=2795793&tool=pmcentrez&rendertype=abstract","journal-title":"Oncogene"},{"key":"226_CR7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2840-8-61","volume":"8","author":"CN Rathcke","year":"2009","unstructured":"Rathcke CN, Vestergaard H. YKL-40-an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol. 2009;8:7.","journal-title":"Cardiovasc Diabetol"},{"key":"226_CR8","doi-asserted-by":"crossref","first-page":"44058","DOI":"10.1074\/jbc.M306792200","volume":"278","author":"M Rehli","year":"2003","unstructured":"Rehli M, Niller HH, Ammon C, Langmann S, Schwarzfischer L, Andreesen R, et al. Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation. J Biol Chem. 2003;278:44058\u201367.","journal-title":"J Biol Chem"},{"key":"226_CR9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/geno.1997.4778","volume":"43","author":"M Rehli","year":"1997","unstructured":"Rehli M, Krause SW, Andreesen R. Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics. 1997;43:221\u20135.","journal-title":"Genomics"},{"key":"226_CR10","doi-asserted-by":"crossref","unstructured":"Qin G, Li X, Chen Z, Liao G, Su Y, Chen Y, et al. Prognostic value of YKL-40 in patients with Glioblastoma: a systematic review and meta-analysis. Mol Neurobiol. 2017;54:3264-70.","DOI":"10.1007\/s12035-016-9878-2"},{"key":"226_CR11","doi-asserted-by":"crossref","first-page":"15332","DOI":"10.1074\/jbc.M110.212514","volume":"286","author":"RA Francescone","year":"2011","unstructured":"Francescone RA, Scully S, Faibish M, Taylor SL, Oh D, Moral L, et al. Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma. J Biol Chem. 2011;286:15332\u201343.","journal-title":"J Biol Chem"},{"key":"226_CR12","doi-asserted-by":"crossref","unstructured":"Xiang W, Menges S, Schlachetzki JC, Meixner H, Hoffmann A-C, Schl\u00f6tzer-Schrehardt U, et al. Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity. Mol. Neurodegener. 2015;10:8.[cited 2015 Aug 18]; Available from: http:\/\/www.molecularneurodegeneration.com\/content\/10\/1\/8","DOI":"10.1186\/s13024-015-0004-0"},{"key":"226_CR13","first-page":"172","volume":"53","author":"JS Johansen","year":"2006","unstructured":"Johansen JS. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull. 2006;53:172\u2013209.","journal-title":"Dan Med Bull"},{"key":"226_CR14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.atherosclerosis.2010.02.035","volume":"211","author":"AE Michelsen","year":"2010","unstructured":"Michelsen AE, Rathcke CN, Skjelland M, Holm S, Ranheim T, Krohg-Sorensen K, et al. Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis. 2010;211:589\u201395. Available from: http:\/\/ac.els-cdn.com\/S0021915010001760\/1-s2.0-S0021915010001760-main.pdf?_tid=8d09dab4-77fd-11e5-a89a-00000aab0f01&acdnat=1445436838_1a64d9b28138f5981ecf641d6062a3d0","journal-title":"Atherosclerosis"},{"key":"226_CR15","doi-asserted-by":"crossref","unstructured":"Bonneh-Barkay D, Bissel SJ, Wang G, Fish KN, Nicholl GCB, Darko SW, et al. YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor. Am J Pathol 2008;173:130\u201343. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=2438291&tool=pmcentrez&rendertype=abstract .","DOI":"10.2353\/ajpath.2008.080045"},{"key":"226_CR16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1742-2094-7-34","volume":"7","author":"D Bonneh-Barkay","year":"2010","unstructured":"Bonneh-Barkay D, Wang G, Starkey A, Hamilton RL, Wiley CA. In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases.J. Neuroinflammation. 2010;7:34. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=2892443&tool=pmcentrez&rendertype=abstract .","journal-title":"J. Neuroinflammation"},{"key":"226_CR17","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1089\/neu.2010.1310","volume":"27","author":"D Bonneh-Barkay","year":"2010","unstructured":"Bonneh-Barkay D, Zagadailov P, Zou H, Niyonkuru C, Figley M, Starkey A, et al. YKL-40 expression in traumatic brain injury: an initial analysis. J Neurotrauma [Internet]. 2010;27:1215\u201323. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=2942903&tool=pmcentrez&rendertype=abstract .","journal-title":"J Neurotrauma [Internet]"},{"key":"226_CR18","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/brain\/awq035","volume":"133","author":"M Comabella","year":"2010","unstructured":"Comabella M, Fern\u00e1ndez M, Martin R, Rivera-Vallv\u00e9 S, Borr\u00e1s E, Chiva C, et al. Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis. Brain. 2010;133:1082\u201393.","journal-title":"Brain"},{"key":"226_CR19","doi-asserted-by":"crossref","unstructured":"Johansen JS, Baslund B, Garbarsch C, Hansen M, Stoltenberg M, Lorenzen I, et al. YKL-40 in giant cells and macrophages from patients with giant cell arteritis. Arthritis Rheum [Internet]. 1999;42:2624\u201330. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10616010 .","DOI":"10.1002\/1529-0131(199912)42:12<2624::AID-ANR17>3.0.CO;2-K"},{"key":"226_CR20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.lungcan.2004.11.011","volume":"48","author":"N Junker","year":"2005","unstructured":"Junker N, Johansen JS, Andersen CB, Kristjansen PE. Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer. Lung Cancer [Internet]. 2005;48:223\u201331. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15829322 .","journal-title":"Lung Cancer [Internet]"},{"key":"226_CR21","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.4049\/jimmunol.181.7.5167","volume":"181","author":"S L\u00e9tuv\u00e9","year":"2008","unstructured":"L\u00e9tuv\u00e9 S, Kozhich A, Arouche N, Grandsaigne M, Reed J, Dombret M, et al. YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. J Immunol. 2008;181:5167\u201373.","journal-title":"J Immunol"},{"key":"226_CR22","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1750-3639.2011.00550.x","volume":"22","author":"D Bonneh-Barkay","year":"2012","unstructured":"Bonneh-Barkay D, Bissel SJ, Kofler J, Starkey A, Wang G, Wiley CA. Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation. Brain Pathol. 2012;22:530\u201346.","journal-title":"Brain Pathol"},{"key":"226_CR23","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","volume":"68","author":"R Craig-Schapiro","year":"2010","unstructured":"Craig-Schapiro R, Perrin RJ, Roe CM, Xiong C, Carter D, Cairns NJ, et al. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer\u2019s disease. Biol Psychiatry. 2010;68:903\u201312.","journal-title":"Biol Psychiatry"},{"key":"226_CR24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2012-120787","volume":"33","author":"B Olsson","year":"2013","unstructured":"Olsson B, Hertze J, Lautner R, Zetterberg H, N\u00e4gga K, H\u00f6glund K, et al. Microglial markers are elevated in the prodromal phase of Alzheimer\u2019s disease and vascular dementia. J Alzheimers Dis. 2013;33:45\u201353.","journal-title":"J Alzheimers Dis"},{"key":"226_CR25","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3233\/JAD-140624","volume":"42","author":"A Antonell","year":"2014","unstructured":"Antonell A, Mansilla A, Rami L, Llad\u00f3 A, Iranzo A, Olives J, et al. Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer\u2019s disease. J Alzheimers Dis. 2014;42:901\u20138.","journal-title":"J Alzheimers Dis"},{"key":"226_CR26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13195-015-0142-1","volume":"7","author":"MI Kester","year":"2015","unstructured":"Kester MI, Teunissen CE, Sutphen C, Herries EM, Ladenson JH, Xiong CJ, et al. Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer\u2019s disease in a memory clinic cohort. Alzheimers Res Ther. 2015;7:9.","journal-title":"Alzheimers Res Ther"},{"key":"226_CR27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.nurt.2010.05.017","volume":"7","author":"A Verkhratsky","year":"2010","unstructured":"Verkhratsky A, Olabarria M, Noristani HN, Yeh CY, Rodriguez JJ. Astrocytes in Alzheimer\u2019s disease. Neurotherapeutics. 2010;7:399\u2013412.","journal-title":"Neurotherapeutics"},{"key":"226_CR28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neurobiolaging.2015.10.022","volume":"38","author":"JD Gispert","year":"2016","unstructured":"Gispert JD, Mont\u00e9 GC, Falcon C, Tucholka A, Rojas S, S\u00e1nchez-Valle R, et al. CSF YKL-40 and pTau181 are related to different cerebral morphometric patterns in early AD. Neurobiol Aging. 2016;38:47\u201355.","journal-title":"Neurobiol Aging"},{"key":"226_CR29","doi-asserted-by":"crossref","first-page":"e16032","DOI":"10.1371\/journal.pone.0016032","volume":"6","author":"RJ Perrin","year":"2011","unstructured":"Perrin RJ, Craig-Schapiro R, Malone JP, Shah AR, Gilmore P, Davis AE, et al. Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer\u2019s disease. PLoS One. 2011;6:e16032.","journal-title":"PLoS One"},{"key":"226_CR30","doi-asserted-by":"crossref","unstructured":"Wildsmith KR, Schauer SP, Smith AM, Arnott D, Zhu Y, Haznedar J, et al. Identification of longitudinally dynamic biomarkers in Alzheimer\u2019s disease cerebrospinal fluid by targeted proteomics. Mol. Neurodegener. 2014;9:22. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24902845%5Cn , http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=PMC4061120 .","DOI":"10.1186\/1750-1326-9-22"},{"key":"226_CR31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000362164","volume":"4","author":"C Rosen","year":"2014","unstructured":"Rosen C, Andersson CH, Andreasson U, Molinuevo JL, Bjerke M, Rami L, et al. Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer\u2019s Disease. Dement Geriatr Cogn Dis Extra. 2014;4:297\u2013304. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4164083\/pdf\/dee-0004-0297.pdf .","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"226_CR32","doi-asserted-by":"crossref","first-page":"e0135458","DOI":"10.1371\/journal.pone.0135458","volume":"10","author":"M Wennstr\u00f6m","year":"2015","unstructured":"Wennstr\u00f6m M, Surova Y, Hall S, Nilsson C, Minthon L, Hansson O, et al. The inflammatory marker YKL-40 is elevated in cerebrospinal fluid from patients with Alzheimer\u2019s but not Parkinson\u2019s disease or dementia with Lewy bodies. PLoS One. 2015;10:e0135458.","journal-title":"PLoS One"},{"key":"226_CR33","doi-asserted-by":"crossref","first-page":"e952","DOI":"10.1038\/tp.2016.194","volume":"6","author":"RW Paterson","year":"2016","unstructured":"Paterson RW, Heywood WE, Heslegrave AJ, Magdalinou NK, Andreasson U, Sirka E, et al. A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer\u2019s disease pathology. Transl. Psychiatry. 2016;6:e952. Available from: http:\/\/www.nature.com\/doifinder\/10.1038\/tp.2016.194 .","journal-title":"Transl. Psychiatry"},{"key":"226_CR34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/JAD-140240","volume":"42","author":"D Alcolea","year":"2014","unstructured":"Alcolea D, Carmona-Iragui M, Suarez-Calvet M, Sanchez-Saudinos MB, Sala I, Anton-Aguirre S, et al. Relationship between beta-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer\u2019s disease. J Alzheimers Dis. 2014;42:157\u201367. Available from: http:\/\/content.iospress.com\/articles\/journal-of-alzheimers-disease\/jad140240 .","journal-title":"J Alzheimers Dis"},{"key":"226_CR35","doi-asserted-by":"crossref","unstructured":"Janelidze S, Hertze J, Zetterberg H, Landqvist Waldo M, Santillo A, Blennow K, et al. Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer\u2019s disease. Ann. Clin. Transl. Neurol. 2015;3 Available from: http:\/\/doi.wiley.com\/10.1002\/acn3.266 .","DOI":"10.1002\/acn3.266"},{"key":"226_CR36","first-page":"86","volume":"2","author":"CE Teunissen","year":"2016","unstructured":"Teunissen CE, Elias N, Koel-Simmelink MJA, Durieux-Lu S, Malekzadeh A, Pham TV, et al. Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics. Alzheimer\u2019s Dement. 2016;2:86\u201394.","journal-title":"Alzheimer\u2019s Dement"},{"key":"226_CR37","unstructured":"Baldacci F, Toschi N, Lista S, Zetterberg H, Blennow K, Kilimann I, et al. Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer\u2019s disease. Alzheimers. Dement. 2017:1\u201311. Available from: http:\/\/www.alzheimersanddementia.com\/article\/S1552-5260(17)30047-X\/abstract . http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28263742 ."},{"key":"226_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms17020206","volume":"17","author":"I L\u00f3pez Gonz\u00e1lez","year":"2016","unstructured":"L\u00f3pez Gonz\u00e1lez I, Garcia-Esparcia P, Llorens F, Ferrer I. Genetic and transcriptomic profiles of inflammation in neurodegenerative diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies. Int J Mol Sci. 2016;17:1\u201323.","journal-title":"Int J Mol Sci"},{"key":"226_CR39","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4161\/pri.26416","volume":"7","author":"F Llorens","year":"2013","unstructured":"Llorens F, Ansoleaga B, Garcia-Esparcia P, Zafar S, Grau-Rivera O, L\u00f3pez-Gonz\u00e1lez I, et al. PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2. Prion. 2013;7:383\u201393. Available from: http:\/\/www.tandfonline.com\/doi\/abs\/10.4161\/pri.26416 .","journal-title":"Prion"},{"key":"226_CR40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fnagi.2014.00198","volume":"6","author":"F Llorens","year":"2014","unstructured":"Llorens F, Lopez-Gonzalez I, Thune K, Carmona M, Zafar S, Andeoletti O, et al. Subtype and regional-specific neuroinflammation in sporadic creutzfeldt-jakob disease. Front Aging Neurosci. 2014;6:198.","journal-title":"Front Aging Neurosci"},{"key":"226_CR41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/NEN.0000000000000176","volume":"74","author":"I Lopez-Gonzalez","year":"2015","unstructured":"Lopez-Gonzalez I, Schluter A, Aso E, Garcia-Esparcia P, Ansoleaga B, LL F, et al. Neuroinflammatory signals in Alzheimer disease and APP\/PS1 transgenic mice: correlations with plaques, tangles, and Oligomeric species. J Neuropathol Exp Neurol. 2015;74:319\u201344. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25756590 .","journal-title":"J Neuropathol Exp Neurol"},{"key":"226_CR42","doi-asserted-by":"crossref","unstructured":"Garcia-Esparcia P, L\u00f3pez-Gonz\u00e1lez I, Grau-Rivera O, Garc\u00eda-Garrido MF, Konetti A, Llorens F, et al. Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms. Front. Neurol. 2017;8 Available from: http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2017.00089\/full .","DOI":"10.3389\/fneur.2017.00089"},{"key":"226_CR43","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(12)70063-7","volume":"11","author":"G Puoti","year":"2012","unstructured":"Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol. 2012;11:618\u201328.","journal-title":"Lancet Neurol"},{"key":"226_CR44","doi-asserted-by":"crossref","unstructured":"Llorens F, Schmitz M, Karch A, Cramm M, Lange P, Gherib K, et al. Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia. Alzheimers Dement. 2015:1\u201313.","DOI":"10.1016\/j.jalz.2015.10.009"},{"key":"226_CR45","unstructured":"Llorens F, Kruse N, Schmitz M, Gotzmann N, Golanska E, Th\u00fcne K, et al. Evaluation of \u03b1-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases. Alzheimer\u2019s Dement. 2016:1\u201310. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1552526016330552 ."},{"key":"226_CR46","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archneurol.2011.189","volume":"68","author":"C Schmidt","year":"2011","unstructured":"Schmidt C, Wolff M, Weitz M, Bartlau T, Korth C, Zerr I. Rapidly progressive Alzheimer disease. Arch Neurol. 2011;68:1124\u201330.","journal-title":"Arch Neurol"},{"key":"226_CR47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, et al. Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol. 2013;12:357\u201367.","journal-title":"Lancet Neurol"},{"key":"226_CR48","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","volume":"43","author":"G Roman","year":"1993","unstructured":"Roman G, Tatemichi T, Erkinjuntti T, Cummings J, Masdeu J, Garcia J, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN international workshop. Neurology. 1993;43:250\u201360.","journal-title":"Neurology"},{"key":"226_CR49","first-page":"939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group* under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease. Neurol Int. 1984;34:939. Available from: http:\/\/www.neurology.org\/content\/34\/7\/939 .","journal-title":"Neurol Int"},{"key":"226_CR50","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132:2659\u201368.","journal-title":"Brain"},{"key":"226_CR51","doi-asserted-by":"crossref","unstructured":"Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RS, et al. Analysis of EEG and CSF 14\u20133-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000;55:811\u20135. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10994001 .","DOI":"10.1212\/WNL.55.6.811"},{"issue":"3","key":"226_CR52","doi-asserted-by":"crossref","first-page":"e1001319","DOI":"10.1371\/journal.ppat.1001319","volume":"7","author":"D Padilla","year":"2011","unstructured":"Padilla D, B\u00e9ringue V, Espinosa JC, Andreoletti O, Jaumain E, Reine F, et al. Sheep and goat BSE propagate more efficiently than cattle BSE in human PrP transgenic mice. PLoS Pathog. 2011;7(3):e1001319.","journal-title":"PLoS Pathog"},{"key":"226_CR53","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal \u03b2-amyloid aggregates, Neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci [Internet]. 2006;26:10129\u201340. Available from: http:\/\/www.jneurosci.org\/content\/26\/40\/10129.abstract .","journal-title":"J Neurosci [Internet]"},{"key":"226_CR54","doi-asserted-by":"crossref","unstructured":"Eimer WA, Vassar R. Neuron loss in the 5XFAD mouse model of Alzheimer\u2019s disease correlates with intraneuronal A\u03b242 accumulation and Caspase-3 activation. Mol. Neurodegener. 2013;8:2. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23316765%5Cn , http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=PMC3552866 .","DOI":"10.1186\/1750-1326-8-2"},{"key":"226_CR55","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3389\/fnins.2015.00410","volume":"9","author":"H Wolf","year":"2015","unstructured":"Wolf H, Hossinger A, Fehlinger A, B\u00fcttner S, Sim V, McKenzie D, et al. Deposition pattern and subcellular distribution of disease-associated prion protein in cerebellar organotypic slice cultures infected with scrapie. Front Neurosci. 2015;9:410.","journal-title":"Front Neurosci"},{"key":"226_CR56","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.410430109","volume":"43","author":"I Zerr","year":"1998","unstructured":"Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol. 1998;43:32\u201340.","journal-title":"Ann Neurol"},{"key":"226_CR57","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.neuron.2011.08.029","volume":"72","author":"I Milosevic","year":"2011","unstructured":"Milosevic I, Giovedi S, Lou X, Raimondi A, Collesi C, Shen H, et al. Recruitment of endophilin to clathrin-coated pit necks is required for efficient vesicle uncoating after fission. Neuron. 2011;72:587\u2013601.","journal-title":"Neuron"},{"key":"226_CR58","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/nprot.2016.120","volume":"11","author":"M Schmitz","year":"2016","unstructured":"Schmitz M, Cramm M, Llorens F, Collins S, Atarashi R, Satoh K, et al. The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases. Nat Protoc. 2016;11:2233\u201342.","journal-title":"Nat Protoc"},{"key":"226_CR59","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1007\/s12035-015-9133-2","volume":"53","author":"M Cramm","year":"2016","unstructured":"Cramm M, Schmitz M, Karch A, Mitrova E, Kuhn F, Schroeder B, et al. Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt-Jakob disease. Mol Neurobiol. 2016;53:1896\u2013904.","journal-title":"Mol Neurobiol"},{"key":"226_CR60","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32\u20135.","journal-title":"Cancer"},{"key":"226_CR61","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s004390051096","volume":"105","author":"O Windl","year":"1999","unstructured":"Windl O, Giese A, Schulz-Schaeffer W, Zerr I, Skworc K, Arendt S, et al. Molecular genetics of human prion diseases in Germany. Hum Genet. 1999;105:244\u201352.","journal-title":"Hum Genet"},{"issue":"11","key":"226_CR62","doi-asserted-by":"crossref","first-page":"e1002985","DOI":"10.1371\/journal.ppat.1002985","volume":"8","author":"J Falsig","year":"2012","unstructured":"Falsig J, Sonati T, Herrmann US, Saban D, Li B, Arroyo K, et al. Prion pathogenesis is faithfully reproduced in cerebellar Organotypic slice cultures. PLoS Pathog. 2012;8(11):e1002985.","journal-title":"PLoS Pathog"},{"key":"226_CR63","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/brain\/awg125","volume":"126","author":"AF Hill","year":"2003","unstructured":"Hill AF. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain. 2003;126:1333\u201346. Available from: http:\/\/brain.oxfordjournals.org\/cgi\/content\/abstract\/126\/6\/1333 .","journal-title":"Brain"},{"key":"226_CR64","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/brain\/awm063","volume":"130","author":"U Heinemann","year":"2007","unstructured":"Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, et al. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain. 2007;130:1350\u20139.","journal-title":"Brain"},{"issue":"4","key":"226_CR65","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El KJ, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405.","journal-title":"Lancet Neurol"},{"issue":"3","key":"226_CR66","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/jnc.13411","volume":"136","author":"MR Minter","year":"2016","unstructured":"Minter MR, Taylor JM, Crack PJ. The contribution of neuroinflammation to amyloid toxicity in Alzheimer\u2019s disease. J. Neurochem. 2016;136(3):457\u201374.","journal-title":"J. Neurochem"},{"key":"226_CR67","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3389\/fncel.2015.00414","volume":"9","author":"RA Radford","year":"2015","unstructured":"Radford RA, Morsch M, Rayner SL, Cole NJ, Pountney DL, Chung RS. The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia. Front. Cell. Neurosci. 2015;9:414. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=4621294&tool=pmcentrez&rendertype=abstract .","journal-title":"Front. Cell. Neurosci"},{"key":"226_CR68","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1042\/BCJ20160505","volume":"474","author":"C Ugbode","year":"2017","unstructured":"Ugbode C, Hu Y, Whalley B, Peers C, Rattray M, Dallas ML. Astrocytic transporters in Alzheimer\u2019s disease. Biochem J [Internet]. 2017;474:333\u201355. Available from: http:\/\/biochemj.org\/lookup\/doi\/10.1042\/BCJ20160505 .","journal-title":"Biochem J [Internet]"},{"key":"226_CR69","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neurobiolaging.2008.05.015","volume":"31","author":"JE Simpson","year":"2010","unstructured":"Simpson JE, Ince PG, Lace G, Forster G, Shaw PJ, Matthews F, et al. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol Aging. 2010;31:578\u201390.","journal-title":"Neurobiol Aging"},{"issue":"1-2","key":"226_CR70","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mrfmmm.2009.08.016","volume":"690","author":"S Fuller","year":"2010","unstructured":"Fuller S, Steele M, M\u00fcnch G. Activated astroglia during chronic inflammation in Alzheimer\u2019s disease-Do they neglect their neurosupportive roles? Mutat. Res. 2010;690(1-2):40\u20139.","journal-title":"Mutat. Res"},{"issue":"6","key":"226_CR71","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bbamcr.2008.11.009","volume":"1793","author":"R Donato","year":"2009","unstructured":"Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, Brozzi F, et al. S100B\u2019s double life: Intracellular regulator and extracellular signal. Biochim. Biophys. Acta. 2009;1793(6):1008\u201322.","journal-title":"Biochim. Biophys. Acta"},{"key":"226_CR72","first-page":"97","volume":"21","author":"LJ Van Eldik","year":"2003","unstructured":"Van Eldik LJ, Wainwright MS. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor. Neurol. Neurosci. 2003;21:97\u2013108. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14530573 .","journal-title":"Restor. Neurol. Neurosci"},{"key":"226_CR73","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1227\/NEU.0b013e318214a81f","volume":"68","author":"AE B\u00f6hmer","year":"2011","unstructured":"B\u00f6hmer AE, Oses JP, Schmidt AP, Per\u00f3n CS, Krebs CL, Oppitz PP, et al. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury. Neurosurgery. 2011;68:1624\u201330.","journal-title":"Neurosurgery"},{"key":"226_CR74","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0304-3940(02)01257-0","volume":"336","author":"A Petzold","year":"2003","unstructured":"Petzold A, Jenkins R, Watt HC, Green AJE, Thompson EJ, Keir G, et al. Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer\u2019s disease. Neurosci Lett. 2003;336:167\u201370.","journal-title":"Neurosci Lett"},{"key":"226_CR75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2017.00289","volume":"9","author":"F Llorens","year":"2017","unstructured":"Llorens F, Schmitz M, Knipper T, Schmidt C, Lange P, Fischer A, et al. Cerebrospinal Fluid Biomarkers of Alzheimer\u2019s Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia. Front. Aging Neurosci. 2017;9:1\u20139. Available from: http:\/\/journal.frontiersin.org\/article\/10.3389\/fnagi.2017.00289\/full .","journal-title":"Front. Aging Neurosci"},{"key":"226_CR76","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","volume":"67","author":"P Sanchez-Juan","year":"2006","unstructured":"Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, S\u00e1anchez-Valle R, Mitrov\u00e1a E, et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology. 2006;67:637\u201343.","journal-title":"Neurology"},{"key":"226_CR77","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1586\/ern.09.111","volume":"9","author":"S Fuller","year":"2009","unstructured":"Fuller S, Munch G, Steele M. Activated astrocytes: a therapeutic target in Alzheimer\u2019s disease? Expert rev Neurother. 2009;9:1585\u201394. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19903019 .","journal-title":"Expert rev Neurother"},{"key":"226_CR78","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/neup.12158","volume":"35","author":"CA Wiley","year":"2015","unstructured":"Wiley CA, Bonneh-Barkay D, Dixon CE, Lesniak A, Wang G, Bissel SJ, et al. Role for mammalian chitinase 3-like protein 1 in traumatic brain injury. Neuropathology. 2015;35:95\u2013106.","journal-title":"Neuropathology"},{"key":"226_CR79","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/NEN.0b013e31826eaee7","volume":"71","author":"D Bonneh-Barkay","year":"2012","unstructured":"Bonneh-Barkay D, Wang GJ, LaFramboise WA, Wiley CA, Bissel SJ. Exacerbation of experimental autoimmune encephalomyelitis in the absence of breast regression protein 39\/Chitinase 3-like 1. J Neuropathol Exp Neurol. 2012;71:948\u201358.","journal-title":"J Neuropathol Exp Neurol"},{"key":"226_CR80","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fnmol.2012.00006","volume":"5","author":"CL Dalgard","year":"2012","unstructured":"Dalgard CL, Cole JT, Kean WS, Lucky JJ, Sukumar G, McMullen DC, et al. The cytokine temporal profile in rat cortex after controlled cortical impact. Front Mol Neurosci. 2012;5:6.","journal-title":"Front Mol Neurosci"},{"key":"226_CR81","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.4049\/jimmunol.1400874","volume":"194","author":"R Bhardwaj","year":"2015","unstructured":"Bhardwaj R, Yester JW, Singh SK, Biswas DD, Surace MJ, Waters MR, et al. RelB\/p50 complexes regulate cytokine-induced YKL-40 expression. J Immunol. 2015;194:2862\u201370.","journal-title":"J Immunol"},{"key":"226_CR82","doi-asserted-by":"crossref","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017; Available from: http:\/\/www.nature.com\/doifinder\/10.1038\/nature21029 .","DOI":"10.1038\/nature21029"},{"key":"226_CR83","doi-asserted-by":"crossref","unstructured":"Lian H, Litvinchuk A, Chiang AC-A, Aithmitti N, Jankowsky JL, Zheng H. Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer\u2019s disease. J. Neurosci, Available from. 2016;36:577\u201389. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26758846 .","DOI":"10.1523\/JNEUROSCI.2117-15.2016"},{"key":"226_CR84","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3233\/JAD-2008-13402","volume":"13","author":"C Schwab","year":"2008","unstructured":"Schwab C, McGeer PL. Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J Alzheimers Dis. 2008;13:359\u201369.","journal-title":"J Alzheimers Dis"},{"key":"226_CR85","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/archneur.57.6.817","volume":"57","author":"CE Shepherd","year":"2000","unstructured":"Shepherd CE, Thiel E, McCann H, Harding AJ, Halliday GM. Cortical inflammation in Alzheimer disease but not dementia with Lewy bodies. Arch. Neurol. 2000;57:817\u201322.","journal-title":"Arch. Neurol"},{"key":"226_CR86","doi-asserted-by":"crossref","unstructured":"Llorens F, Kruse N, Karch A, Schmitz M, Zafar S, Gotzmann N, et al. Validation of \u03b1-Synuclein as a CSF biomarker for sporadic Creutzfeldt-Jakob disease. Mol. Neurobiol. 2017:1\u20139. Available from: http:\/\/link.springer.com\/10.1007\/s12035-017-0479-5 .","DOI":"10.1007\/s12035-017-0479-5"},{"key":"226_CR87","doi-asserted-by":"crossref","unstructured":"Stoeck K, Schmitz M, Ebert E, Schmidt C, Zerr I. Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer\u00bfs disease and multiple sclerosis. J. Neuroinflammation, Available from. 2014;11:170. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25315814 .","DOI":"10.1186\/s12974-014-0170-y"},{"key":"226_CR88","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000454802","volume":"43","author":"F Llorens","year":"2017","unstructured":"Llorens F, Karch A, Golanska E, Schmitz M, Lange P, Sikorska B, et al. Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutzfeldt-Jakob Disease: A Validation Study for Previously Established Cutoffs. Dement. Geriatr. Cogn. Disord. 2017;43:71\u201380. Available from: https:\/\/www.karger.com\/?doi=10.1159\/000454802 .","journal-title":"Dement. Geriatr. Cogn. Disord"},{"key":"226_CR89","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13195-015-0161-y","volume":"7","author":"K Hellwig","year":"2015","unstructured":"Hellwig K, Kvartsberg H, Portelius E, Andreasson U, Oberstein TJ, Lewczuk P, et al. Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer\u2019s disease. Alzheimers. Res. Ther. 2015;7:74. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=4690296&tool=pmcentrez&rendertype=abstract .","journal-title":"Alzheimers. Res. Ther"},{"key":"226_CR90","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12017-011-8147-9","volume":"13","author":"N Mattsson","year":"2011","unstructured":"Mattsson N, Tabatabaei S, Johansson P, Hansson O, Andreasson U, M\u00e5nsson JE, et al. Cerebrospinal fluid microglial markers in Alzheimer\u2019s disease: elevated chitotriosidase activity but lack of diagnostic utility. NeuroMolecular Med. 2011;13:151\u20139.","journal-title":"NeuroMolecular Med"},{"key":"226_CR91","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2967\/jnumed.110.087031","volume":"53","author":"SF Carter","year":"2012","unstructured":"Carter SF, Scholl M, Almkvist O, Wall A, Engler H, Langstrom B, et al. Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by 11C\u2013Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining 11C\u2013Pittsburgh Compound B and 18F\u2013FDG. J. Nucl. Med. 2012;53:37\u201346.","journal-title":"J. Nucl. Med"},{"issue":"1","key":"226_CR92","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40478-017-0431-y","volume":"5","author":"F Llorens","year":"2017","unstructured":"Llorens F, Th\u00fcne K, Sikorska B, Schmitz M, Tahir W, Fern\u00e1ndez-borges N. Altered Ca 2 + homeostasis induces Calpain- Cathepsin axis activation in sporadic Creutzfeldt-Jakob disease. Acta Neuropathol Commun. 2017;5(1):35.","journal-title":"Acta Neuropathol Commun"},{"key":"226_CR93","doi-asserted-by":"crossref","unstructured":"Gispert JD, Mont\u00e9 GC, Su\u00e1rez-Calvet M, Falcon C, Tucholka A, Rojas S, et al. The {APOE} \u03b54 genotype modulates {CSF} YKL-40 levels and their structural brain correlates in the continuum of Alzheimer disease but not those of sTREM2. Alzheimer\u2019s Dement. Diagnosis, Assess. Dis. Monit. 2016;6 Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S2352872916300653 .","DOI":"10.1016\/j.dadm.2016.12.002"},{"key":"226_CR94","first-page":"1","volume":"0","author":"F Llorens","year":"2016","unstructured":"Llorens F, Thune K, Schmitz M, Ansoleaga B, Frau-Mendez MA, Cramm M, et al. Identification of new molecular alterations in fatal familial insomnia. Hum Mol Genet. 2016;0:1\u201320.","journal-title":"Hum Mol Genet"},{"key":"226_CR95","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ana.410380107","volume":"38","author":"P Parchi","year":"1995","unstructured":"Parchi P, Castellani R, Cortelli P, Montagna P, Chen SG, Petersen RB, et al. Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann Neurol. 1995;38:21\u20139.","journal-title":"Ann Neurol"},{"key":"226_CR96","doi-asserted-by":"crossref","unstructured":"Ladogana A, Sanchez-Juan P, Mitrova E, Green A, Cuadrado-Corrales N, Sanchez-Valle R, et al. Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol, Available from. 2009;256:1620\u20138. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19444528 .","DOI":"10.1007\/s00415-009-5163-x"},{"key":"226_CR97","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","volume":"118","author":"GG Kov\u00e1cs","year":"2005","unstructured":"Kov\u00e1cs GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, van Duijn C, et al. Genetic prion disease: the EUROCJD experience. Hum Genet. 2005;118:166\u201374.","journal-title":"Hum Genet"},{"key":"226_CR98","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/bmb\/66.1.213","volume":"66","author":"P Gambetti","year":"2003","unstructured":"Gambetti P, Kong Q, Zou W, Parchi P, Chen SG. Sporadic and familial CJD: Classification and characterisation. Br. Med. Bull. 2003;66:213\u201339.","journal-title":"Br. Med. Bull"},{"key":"226_CR99","doi-asserted-by":"crossref","unstructured":"Shahim P, Portelius E, Brody DL. Astroglial activation and altered amyloid metabolism in human repetitive concussion. 2017;","DOI":"10.1212\/WNL.0000000000003816"},{"key":"226_CR100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4137\/JCNSD.S13821","volume":"6","author":"C Hjalmarsson","year":"2014","unstructured":"Hjalmarsson C, Bjerke M, Andersson B, Blennow K, Zetterberg H, Aberg ND, et al. Neuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic stroke. J. Cent. Nerv. Syst. Dis. 2014;6:51\u20138. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=4039292&tool=pmcentrez&rendertype=abstract .","journal-title":"J. Cent. Nerv. Syst. Dis"},{"key":"226_CR101","doi-asserted-by":"crossref","unstructured":"Rymo I, Kern S, Bjerke M, Zetterberg H, Marlow T, Blennow K, et al. CSF YKL-40 and GAP-43 are related to suicidal ideation in older women. Acta Psychiatr. Scand. 2017:351\u20137. Available from: http:\/\/doi.wiley.com\/10.1111\/acps.12701 .","DOI":"10.1111\/acps.12701"},{"key":"226_CR102","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1503\/jpn.140183","volume":"40","author":"J Jakobsson","year":"2015","unstructured":"Jakobsson J, Bjerke M, Sahebi S, Isgren A, Ekman CJ, Sellgren C, et al. Monocyte and microglial activation in patients with mood-stabilized bipolar disorder. J Psychiatry Neurosci. 2015;40:250\u20138.","journal-title":"J Psychiatry Neurosci"},{"key":"226_CR103","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0197-4580(01)00236-6","volume":"23","author":"B Van Everbroeck","year":"2002","unstructured":"Van Everbroeck B, Dewulf E, Pals P, L\u00fcbke U, Martin JJ, Cras P. The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease. Neurobiol Aging. 2002;23:59\u201364.","journal-title":"Neurobiol Aging"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-017-0226-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T00:31:36Z","timestamp":1659832296000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-017-0226-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,10]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["226"],"URL":"https:\/\/doi.org\/10.1186\/s13024-017-0226-4","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,10]]},"article-number":"83"}}